drug

(formoterol fumarate + glycopyrrolate)

Marketedupdated 2mo ago

by AstraZeneca Pharmaceuticals LP

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Patent cliff

source: FDA Orange Book

first barrier falls

May 28, 2030

~3.9 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (7)

Mar 17, 2031method-of-use (U-2889)US 88152584.7y
May 28, 2030formulationUS 107167533.9y
May 28, 2030method-of-use (U-2889)US 83242663.9y
May 28, 2030method-of-use (U-2889)US 87038063.9y
May 28, 2030formulationUS 88087133.9y
May 28, 2030method-of-use (U-2889)US 94150093.9y
May 28, 2030formulationUS 94631613.9y

Data sources

ClinicalTrials.gov

last refreshed 11m ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?